Literature DB >> 12217864

Spatial repression of PCNA by p53 during kidney development.

Zubaida Saifudeen1, Jessica Marks, Hong Du, Samir S El-Dahr.   

Abstract

Transcriptional repression is a key mechanism for the spatial specification of gene expression and cell fate determination. During kidney development, proliferating cell nuclear antigen (PCNA) is expressed in the nephrogenic zone and is downregulated rapidly as renal epithelial cells enter terminal differentiation and acquire functional characteristics. Our laboratory reported that the transcription factor p53 stimulates the terminal differentiation of renal epithelial cells by means of transcriptional activation of renal function genes (Saifudeen Z, Dipp S, and El-Dahr SS. J Clin Invest 109: 1021-1030, 2002). Because p53-induced growth arrest correlates with downregulation of PCNA gene expression, we examined the impact of p53 inactivation on PCNA expression in mice and evaluated the effect of p53 on PCNA transcription. Immunohistochemistry revealed that the transition from nephrogenesis to terminal epithelial cell differentiation correlates with accumulation of the transcription factor p53. Importantly, the spatially restricted pattern of PCNA expression is disrupted in kidneys of p53-deficient pups, in which there was a redistribution of PCNA expression into the differentiation zone (without a change in total kidney PCNA content) and distortion of the tubular architecture. Electrophoretic mobility shift assays revealed that the binding of kidney nuclear extracts to the p53 response elements in human and rat PCNA promoters is developmentally regulated. Transient transfection assays performed in p53-deficient HeLa cells revealed that exogenous p53 strongly represses transcription from human PCNA promoter-reporter constructs. Interestingly, deletion of the p53-binding site confers enhanced responsiveness to p53-mediated repression, suggesting that transcriptional repression of PCNA by p53 is achieved by a mechanism other than direct DNA binding. On the basis of these results, we propose the hypothesis that p53-mediated transcriptional repression plays a role in the spatial restriction of PCNA gene expression during normal renal development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217864     DOI: 10.1152/ajprenal.00114.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  15 in total

1.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

2.  Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells.

Authors:  Matthew LeBoeuf; Anne Terrell; Sohum Trivedi; Satrajit Sinha; Jonathan A Epstein; Eric N Olson; Edward E Morrisey; Sarah E Millar
Journal:  Dev Cell       Date:  2010-11-18       Impact factor: 12.270

Review 3.  Transcriptional control of terminal nephron differentiation.

Authors:  Samir S El-Dahr; Karam Aboudehen; Zubaida Saifudeen
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

4.  Repression of Interstitial Identity in Nephron Progenitor Cells by Pax2 Establishes the Nephron-Interstitium Boundary during Kidney Development.

Authors:  Natalie Naiman; Kaoru Fujioka; Mari Fujino; M Todd Valerius; S Steven Potter; Andrew P McMahon; Akio Kobayashi
Journal:  Dev Cell       Date:  2017-05-22       Impact factor: 12.270

5.  Alpha-tocopherol prevents intrauterine undernutrition-induced oligonephronia in rats.

Authors:  Leucio D Vieira-Filho; Edjair Vicente Cabral; Felipe T J Santos; Terezila M Coimbra; Ana D O Paixão
Journal:  Pediatr Nephrol       Date:  2011-05-24       Impact factor: 3.714

Review 6.  The MDM2-p53 pathway: multiple roles in kidney development.

Authors:  Samir El-Dahr; Sylvia Hilliard; Karam Aboudehen; Zubaida Saifudeen
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

7.  Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors.

Authors:  Anke Olliges; Stefanie Wimmer; Rolf M Nüsing
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

9.  Effects of early postnatal hyperglycaemia on renal cortex maturity, endothelial nitric oxide synthase expression and nephron deficit in mice.

Authors:  Ana Rosa Cunha; Marcia Barbosa Aguila; Carlos Alberto Mandarim-de-Lacerda
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

10.  p53 regulates metanephric development.

Authors:  Zubaida Saifudeen; Susana Dipp; Jana Stefkova; Xiao Yao; Sarah Lookabaugh; Samir S El-Dahr
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.